Composition
- Active ingredients
- RIVAROXABAN 20MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RIVAROXABAN 1MG/ML · For suspensionNDA215859-001 · Prescription
- RIVAROXABAN 20MG · TabletThis page
- RIVAROXABAN 10MG · TabletNDA202439-001 · Prescription
- RIVAROXABAN 2.5MG · TabletNDA202439-004 · Prescription
- RIVAROXABAN 15MG · TabletNDA202439-002 · Prescription
- RIVAROXABAN 20MG · TabletNDA022406-003 · Prescription
- RIVAROXABAN 10MG · TabletNDA022406-001 · Prescription
- RIVAROXABAN 2.5MG · TabletNDA022406-004 · Prescription
- RIVAROXABAN 15MG · TabletNDA022406-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA202439.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Xarelto
- Active substance
- rivaroxaban
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Janssen Pharms
- Status
- Prescription
- FDA approval
- 4 Nov 2011
- Application
- NDA202439-003



